Solid Biosciences (SLDB) Enterprise Value (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.65% |
| Dec 31, 2025 | 20.45% |
| Sep 30, 2025 | 11.92% |
| Jun 30, 2025 | -27.29% |
| Mar 31, 2025 | -162.52% |
| Dec 31, 2024 | 53.11% |
| Sep 30, 2024 | 10.06% |
| Jun 30, 2024 | 7.67% |
| Mar 31, 2024 | -66.67% |
| Dec 31, 2023 | 13.47% |
| Sep 30, 2023 | 10.80% |
| Jun 30, 2023 | 13.65% |
| Mar 31, 2023 | 13.20% |
| Dec 31, 2022 | -50.34% |
| Sep 30, 2022 | -160.61% |
| Jun 30, 2022 | 69.70% |
| Mar 31, 2022 | 13.35% |
| Dec 31, 2021 | -89.29% |
| Sep 30, 2021 | 45.31% |
| Jun 30, 2021 | 25.25% |
| Mar 31, 2021 | -73.14% |
| Dec 31, 2020 | -525.36% |
| Sep 30, 2020 | 39.18% |
| Jun 30, 2020 | 24.38% |
| Mar 31, 2020 | 35.45% |
| Dec 31, 2019 | 21.20% |
| Sep 30, 2019 | -56.53% |
| Jun 30, 2019 | 28.78% |
| Mar 31, 2019 | 22.37% |
| Dec 31, 2018 | 15.89% |
| Sep 30, 2018 | 0.31% |
| Jun 30, 2018 | 11.55% |
| Mar 31, 2018 | -216.30% |
| Dec 31, 2017 | -246.17% |
| Sep 30, 2017 | 53.90% |
| Jun 30, 2017 | -11.79% |